Cargando…

COVID-19 therapy, from lung disease to systemic disorder

Detalles Bibliográficos
Autores principales:	Pitchford, Simon, Zanella, Isabella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	COVID-19 therapy edited by Isabella Zanella & Simon Pitchford
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973018/ https://www.ncbi.nlm.nih.gov/pubmed/35382154 http://dx.doi.org/10.1016/j.crphar.2022.100099

Ejemplares similares

Strategies for drug repurposing against coronavirus targets
por: Smith, Poppy O., et al.
Publicado: (2021)

Ligands can differentially and temporally modulate GPCR interaction with 14-3-3 isoforms
por: Eishingdrelo, Haifeng, et al.
Publicado: (2022)

Host directed therapies: COVID-19 and beyond
por: Tripathi, Devavrat, et al.
Publicado: (2021)

Pathophysiology and possible treatments for olfactory-gustatory disorders in patients affected by COVID-19
por: Neta, Francisca Idalina, et al.
Publicado: (2021)

Hypoxia may be a determinative factor in COVID-19 progression
por: Grieb, Pawel, et al.
Publicado: (2021)

Teriflunomide: A possible effective drug for the comprehensive treatment of COVID-19
por: Rabie, Amgad M.
Publicado: (2021)

Can NLRP3 inhibitors improve on dexamethasone for the treatment of COVID-19?
por: Hooftman, Alexander, et al.
Publicado: (2021)

A research update: Significance of cytokine storm and diaphragm in COVID-19
por: Mittal, Ashwani, et al.
Publicado: (2021)

Physiopathology and prospectives for therapeutic treatment of pulmonary fibrotic state in COVID-19 patients
por: Vitiello, Antonio, et al.
Publicado: (2021)

Can the application of graphene oxide contribute to the fight against COVID-19? Antiviral activity, diagnosis and prevention
por: Rhazouani, Asmaa, et al.
Publicado: (2021)

Potential inhibitors of SARS-CoV-2 (COVID 19) proteases PL(pro) and M(pro)/ 3CL(pro): molecular docking and simulation studies of three pertinent medicinal plant natural components
por: Verma, Devvret, et al.
Publicado: (2021)

Lung Barrier Function in COVID-19?
por: Sivabakya, T. K., et al.
Publicado: (2020)

Lung Ultrasound Findings in Patients with COVID-19
por: Marggrander, Daniel T., et al.
Publicado: (2020)

Recent progress in the development of potential drugs against SARS-CoV-2
por: Chen, Jianmin, et al.
Publicado: (2021)

The development of biologics to target SARS-CoV2: Treatment potential of antibodies in patient groups with poor immune response
por: Migo, William, et al.
Publicado: (2021)

Comparison of anti-SARS-CoV-2 activity and intracellular metabolism of remdesivir and its parent nucleoside
por: Tao, Sijia, et al.
Publicado: (2021)

Systematic review on role of structure based drug design (SBDD) in the identification of anti-viral leads against SARS-Cov-2
por: Bajad, Nilesh Gajanan, et al.
Publicado: (2021)

Artificial intelligence-driven drug repurposing and structural biology for SARS-CoV-2
por: Prasad, Kartikay, et al.
Publicado: (2021)

Lung Ultrasound and Respiratory Pathophysiology in Mechanically Ventilated COVID-19 Patients—an Observational Trial
por: Rojatti, Marco, et al.
Publicado: (2020)

The impact of the COVID-19 pandemic on people with neurological disorders: an urgent need to enhance the health care system’s preparedness
por: Zullo, Silvia, et al.
Publicado: (2021)

Functional movement disorders in a patient with COVID-19
por: Piscitelli, Daniele, et al.
Publicado: (2020)

Functional neurological disorder after COVID-19 vaccination
por: Ercoli, Tommaso, et al.
Publicado: (2021)

COVID-19: is it just a lung disease? A case-based review
por: Spuntarelli, Valerio, et al.
Publicado: (2020)

Monoclonal antibody therapy for prevention of severe disease in nosocomial COVID-19
por: Zimilover, Adam, et al.
Publicado: (2022)

Qualitative smell/taste disorders as sequelae of acute COVID-19
por: Ercoli, Tommaso, et al.
Publicado: (2021)

Real‐world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID‐19 disease) in patients with multiple myeloma receiving systemic anti‐cancer therapy
por: Cook, Gordon, et al.
Publicado: (2020)

Early caloric deficit is associated with a higher risk of death in invasive ventilated COVID-19 patients
por: Cereda, Emanuele, et al.
Publicado: (2022)

Brain microvascular occlusive disorder in COVID-19: a case report
por: Saitta, Laura, et al.
Publicado: (2020)

Virtual visits for chronic neurologic disorders during COVID-19 pandemic
por: Rosellini, Irene, et al.
Publicado: (2021)

Lung involvement correlates with disability in MS patients with COVID-19 pneumonia
por: Immovilli, Paolo, et al.
Publicado: (2022)

Diarrhea Is Associated with Increased Severity of Disease in COVID-19: Systemic Review and Metaanalysis
por: Ghimire, Subash, et al.
Publicado: (2021)

Allergic disorders and susceptibility to and severity of COVID-19: A nationwide cohort study
por: Yang, Jee Myung, et al.
Publicado: (2020)

Lung Ultrasound in COVID-19: Clinical Correlates and Comparison with Chest Computed Tomography
por: Portale, Grazia, et al.
Publicado: (2021)

Chemokines and eicosanoids fuel the hyperinflammation within the lungs of patients with severe COVID-19
por: Zaid, Younes, et al.
Publicado: (2021)

Lung Manifestations of COVID-19 on Chest Radiographs—Indian Experience in a High-Volume Dedicated COVID center
por: Nagarajan, Bhagyam, et al.
Publicado: (2021)

Prognostic Value of Lung Ultrasonography in Older Nursing Home Residents Affected by COVID-19
por: Veronese, Nicola, et al.
Publicado: (2020)

Multivessel coronary thrombosis in a COVID-19 patient: Lungs are not always a culprit
por: Kuzemczak, Michał, et al.
Publicado: (2021)

Efficacy of Plasmapheresis and Immunoglobulin Replacement Therapy (IVIG) on Patients with COVID-19
por: Pourahmad, Ramtin, et al.
Publicado: (2020)

Neurological manifestations of COVID-19 in patients: from path physiology to therapy
por: Merino, J. J., et al.
Publicado: (2021)

Global sharing of COVID‐19 therapies during a “New Normal”
por: Jecker, Nancy S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d2s853n36h997pts042tcvh05g